Predictors of pulmonary exacerbation treatment in cystic fibrosis

Most studies of pulmonary exacerbations (PEx) in cystic fibrosis (CF) focus on intravenous (IV)-treated PEx, though most PEx are treated with oral antibiotics. Our objectives were to describe predictors of antibiotic choice and outcomes for PEx initially identified in clinic.

Source: Journal of Cystic Fibrosis - June 26, 2019 Category: Respiratory Medicine Authors: Don B. Sanders, Joshua S. Ostrenga, Margaret Rosenfeld, Aliza K. Fink, Michael S. Schechter, Gregory S. Sawicki, Patrick A. Flume, Wayne J. Morgan Tags: Original Article Source Type: research